A carregar...
P04.12 The preclinical efficacy study using mesenchymal stem cells expressing TRAIL & CD for glioblastoma.
BACKGROUND: Our previous study using mesenchymal stem cells (MSCs) as delivery vehicles for tumor necrosis factor-related apoptosis inducing ligand (TRAIL) showed an anti-tumor effect in vitro and in vivo for glioblastoma. However, because most malignant glioma cells exhibit TRAIL resistance, we nee...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144671/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.246 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|